Medpace Holdings, Inc. (MEDP) Return on equity 2016–2025
Medpace Holdings, Inc. (MEDP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
98.3%FY2025 · since FY2016: 2.2% → 98.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 98.3% | +49.3 pp |
| FY2024 | 49.0% | -1.6 pp |
| FY2023 | 50.6% | -12.9 pp |
| FY2022 | 63.5% | +44.4 pp |
| FY2021 | 19.1% | +1.0 pp |
| FY2020 | 18.0% | +4.2 pp |
| FY2019 | 13.8% | +1.6 pp |
| FY2018 | 12.2% | +4.5 pp |
| FY2017 | 7.7% | +5.5 pp |
| FY2016 | 2.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice